Billing and Coding: Rezum® System for Benign Prostatic

The Rezum System (convective water vapor thermal therapy) is covered for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia when used for FDA-cleared indications. Claims must be reported using CPT 53854 (not CPT 53852) with the procedure documented on the UB-04 (FL80) for facility claims or CMS-1500 (Box 19) for physician claims; these coding rules are effective January 1, 2019.

"Rezum System (convective water vapor thermal therapy) is covered to relieve lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) when used for FDA-cleared indications."

Sign up to see full coverage criteria, indications, and limitations.